跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Triplixam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Triplixam
Approved
STANDARD
Triplixam
Servier (Ireland) Industries Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1f39bf7ad3763965
Company
Servier (Ireland) Industries Ltd.
Type
Standard
Approval Details
Approval Id
1f39bf7ad3763965
Drug Approval Philippines Name
Triplixam
Product Name
Triplixam
Registration Number
DR-XY44976
Brand Name
Triplixam
Generic Name
Perindopril Arginine + Indapamide + Amlodipine (as besilate)
Dosage Form
Film-Coated Tablet
Dosage Strength
5 mg/ 1.25 mg/ 5 mg
Manufacturer
Servier (Ireland) Industries Ltd.
Importer
Servier Philippines, Inc.
Distributor
Zuellig Pharma Corp.
Company Detail Path
/organization/servier-ireland-industries-ltd
Issuance Date
29 April 2022
Expiry Date
29 December 2025
Pharmacologic Category
Antihypertensive (ACE Inhibitor-Diuretic-Calcium Channel Blocker Combination)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1f39bf7ad3763965
Type
Standard
Back to Philippines FDA Approvals